Détails

Source

TAO Daily

Publication

26 août à 22h24

Lien direct

https://taodaily.io/minos-adds-chromosomes-16-and-17-taking-sn107-to-seven-live-targets/

Contenu source (brut)

<p class="wp-block-paragraph">Minos (SN107) has added <strong>chromosomes 16 and 17</strong> to its live genomics benchmark, bringing the number of chromosomes currently covered by the network to <strong>seven</strong>.</p> <p class="wp-block-paragraph">The expansion brings two particularly important regions of the human genome into Minos’ live testing environment.</p> <figure class="wp-block-embed is-type-rich is-provider-x wp-block-embed-x"><div class="wp-block-embed__wrapper"> <div class="embed-x"><blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">Chromosomes 17 and 16 are now live on Minos, bringing the total number of chromosomes in the network to 7.<br><br>Chr17 carries BRCA1 and TP53, while Chr16 contains key genes implicated in kidney disease and blood disorders. <a href="https://t.co/Jw6S1BBn0n">pic.twitter.com/Jw6S1BBn0n</a></p>&mdash; Minos (@theminos_ai) <a href="https://x.com/theminos_ai/status/2092426490545672223?ref_src=twsrc%5Etfw">August 26, 2026</a></blockquote><script async src="https://platform.x.com/widgets.js" charset="utf-8"></script></div> </div></figure> <p class="wp-block-paragraph"><strong>Chromosome 17</strong> contains major cancer-related genes including <strong>BRCA1</strong> and <strong>TP53</strong>. BRCA1 plays a critical role in DNA repair and is strongly associated with hereditary breast and ovarian cancer, while TP53 is one of the most important tumor-suppressor genes in human biology.</p> <p class="wp-block-paragraph"><strong>Chromosome 16</strong> brings another set of clinically significant targets. It contains <strong>PKD1</strong>, a major gene associated with autosomal dominant polycystic kidney disease, as well as <strong>HBA1 and HBA2</strong>, which are involved in alpha-thalassemia and other blood disorders.</p> <p class="wp-block-paragraph">That makes the latest expansion more than simply two additional chromosomes. Minos is now testing variant detection across genomic regions directly relevant to <strong>cancer, kidney disease and inherited blood disorders</strong>.</p> <p class="wp-block-paragraph">The move also advances Minos’ longer-term objective of expanding its genomic coverage toward the <strong>entire human genome</strong>.</p> <p class="wp-block-paragraph">With chromosomes 16 through 22 now live, the subnet has moved beyond its initial compact targets and into a broader set of clinically significant regions.</p> <p class="wp-block-paragraph">For Minos, every new chromosome expands the range of genomic variation that miners must accurately detect and gives the network more ground-truth data to work with.</p> <p class="wp-block-paragraph"><strong>Read more about Minos below:</strong></p> <figure class="wp-block-embed is-type-wp-embed is-provider-the-tao-daily wp-block-embed-the-tao-daily"><div class="wp-block-embed__wrapper"> <blockquote class="wp-embedded-content" data-secret="FuDtMt1oyq"><a href="https://taodaily.io/why-minos-bittensor-subnet-107-could-become-a-unicorn/">Why Minos (Bittensor Subnet 107) Could Become a Unicorn</a></blockquote><iframe class="wp-embedded-content" sandbox="allow-scripts" security="restricted" style="position: absolute; visibility: hidden;" title="“Why Minos (Bittensor Subnet 107) Could Become a Unicorn” — The TAO Daily" src="https://taodaily.io/why-minos-bittensor-subnet-107-could-become-a-unicorn/embed/#?secret=HjzXr6lXNp#?secret=FuDtMt1oyq" data-secret="FuDtMt1oyq" width="500" height="282" frameborder="0" marginwidth="0" marginheight="0" scrolling="no"></iframe> </div></figure>